Enterolife Aqua Oral Suspension contains Bacillus Clausii spores (2 million spores per dose), a probiotic agent used to restore and maintain the natural balance of intestinal microflora. This medication is indicated for the prevention and treatment of gastrointestinal disorders associated with dysbiosis, such as antibiotic-associated diarrhea, acute and chronic diarrhea, and irritable bowel syndrome. Bacillus Clausii is a non-pathogenic, spore-forming bacterium that survives gastric acidity and colonizes the gut, where it exerts beneficial effects by inhibiting the growth of pathogenic bacteria and modulating the immune response. Enterolife Aqua Oral Suspension is particularly useful in patients undergoing antibiotic therapy, as it helps to prevent the disruption of normal gut flora caused by broad-spectrum antibiotics. The suspension form allows for easy administration, especially in pediatric and geriatric populations. The product should be used as directed by a healthcare professional, with dosage adjusted according to the severity of the condition and patient age. It is generally well tolerated, with minimal adverse effects reported. Caution is advised in immunocompromised patients. Enterolife Aqua Oral Suspension is an effective adjunct in the management of gastrointestinal disturbances related to microbial imbalance.